These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4033937)

  • 1. Duchenne muscular dystrophy: normal ATP turnover in cultured cells.
    Fox IH; Shefner R; Palmieri GM; Bertorini TE
    Neurology; 1985 Oct; 35(10):1521-4. PubMed ID: 4033937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duchenne muscular dystrophy: normal ATP turnover in cultured cells.
    Fox IH; Shefner R; Palmieri GM; Bertorini T
    Adv Exp Med Biol; 1986; 195 Pt B():493-9. PubMed ID: 3766238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic allopurinol and adenine therapy in Duchenne muscular dystrophy: effects on muscle function, nucleotide degradation, and muscle ATP and ADP content.
    Bertorini TE; Palmieri GM; Griffin J; Chesney C; Pifer D; Verling L; Airozo D; Fox IH
    Neurology; 1985 Jan; 35(1):61-5. PubMed ID: 3880875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duchenne muscular dystrophy: adenosine triphosphate and creatine phosphate content in muscle.
    Samaha FJ; Davis B; Nagy B
    Neurology; 1981 Jul; 31(7):916-9. PubMed ID: 7195521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein degradation in cultured skeletal muscle from Duchenne muscular dystrophy patients.
    Neville HE; Harrold S
    Muscle Nerve; 1985; 8(3):253-7. PubMed ID: 4058470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte ATP in Duchenne dystrophy: effects of ouabain and propranolol.
    Igisu H; Mawatari S; Kuroiwa Y
    Neurology; 1979 Jul; 29(7):992-5. PubMed ID: 157442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free cytoplasmic Ca++ at rest and after cholinergic stimulus is increased in cultured muscle cells from Duchenne muscular dystrophy patients.
    Mongini T; Ghigo D; Doriguzzi C; Bussolino F; Pescarmona G; Pollo B; Schiffer D; Bosia A
    Neurology; 1988 Mar; 38(3):476-80. PubMed ID: 3347352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein metabolism in Duchenne muscular dystrophy, monoclonal and mixed skeletal muscle cultures.
    Corbett AJ
    Clin Exp Neurol; 1987; 24():214-9. PubMed ID: 3268348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients.
    Ferrari D; Munerati M; Melchiorri L; Hanau S; di Virgilio F; Baricordi OR
    Am J Physiol; 1994 Oct; 267(4 Pt 1):C886-92. PubMed ID: 7524344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular protein degradation in cultures of dystrophic muscle cells and fibroblasts.
    McElligott MA; Dice JF
    Exp Cell Res; 1984 Feb; 150(2):442-51. PubMed ID: 6363108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal protein metabolism in skin fibroblasts in vitro from patients with Duchenne muscular dystrophy.
    Rodemann HP; Bayreuther K; Schumacher E
    Biochem Biophys Res Commun; 1987 May; 145(1):1-9. PubMed ID: 3593332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal protein synthesis in cultured skin fibroblast cells obtained from patients with Duchenne muscular dystrophy.
    Pöche H; Schulze H
    J Neurol Sci; 1985 Oct; 70(3):295-304. PubMed ID: 4056825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes.
    Younkin DP; Berman P; Sladky J; Chee C; Bank W; Chance B
    Neurology; 1987 Jan; 37(1):165-9. PubMed ID: 3796830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal collagen metabolism in cultured skin fibroblasts from patients with Duchenne muscular dystrophy.
    Rodemann HP; Bayreuther K
    Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5130-4. PubMed ID: 6591184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy.
    Newman RJ; Bore PJ; Chan L; Gadian DG; Styles P; Taylor D; Radda GK
    Br Med J (Clin Res Ed); 1982 Apr; 284(6322):1072-4. PubMed ID: 6802410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential effects of calcium starvation on Duchenne muscular dystrophy fibroblasts.
    Mone J; Lefkowitz SS
    Proc Soc Exp Biol Med; 1988 Mar; 187(3):267-72. PubMed ID: 3347605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no effect of allopurinol or ribose.
    Griffiths RD; Cady EB; Edwards RH; Wilkie DR
    Muscle Nerve; 1985; 8(9):760-7. PubMed ID: 3935926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen synthesis in cultured myoblasts and myotubes from patients with Duchenne muscular dystrophy.
    de Jong L; Wolterman RA; Hillarius S; Bolhuis PA
    J Neurol Sci; 1987 Dec; 82(1-3):271-80. PubMed ID: 3440869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical investigations in cultured skin fibroblasts from patients with Duchenne muscular dystrophy.
    Pena SD; Vust A; Tucker D; Hamerton JL; Wrogemann K
    Clin Genet; 1978 Jul; 14(1):50-4. PubMed ID: 679522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional staging of Duchenne muscular dystrophy using in vivo 31P MR spectroscopy.
    Ikehira H; Nishikawa S; Matsumura K; Hasegawa T; Arimizu N; Tateno Y
    Radiat Med; 1995; 13(2):63-5. PubMed ID: 7667509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.